Regeneron Pharmaceuticals Inc (REGN)
906.80
-0.10
(-0.01%)
USD |
NASDAQ |
Apr 24, 16:00
906.80
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price to Book Value: 3.832 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 3.833 |
| April 22, 2024 | 3.804 |
| April 19, 2024 | 3.790 |
| April 18, 2024 | 3.778 |
| April 17, 2024 | 3.808 |
| April 16, 2024 | 3.779 |
| April 15, 2024 | 3.797 |
| April 12, 2024 | 3.823 |
| April 11, 2024 | 3.889 |
| April 10, 2024 | 3.956 |
| April 09, 2024 | 3.989 |
| April 08, 2024 | 3.966 |
| April 05, 2024 | 3.984 |
| April 04, 2024 | 3.960 |
| April 03, 2024 | 4.019 |
| April 02, 2024 | 4.034 |
| April 01, 2024 | 4.096 |
| March 28, 2024 | 4.068 |
| March 27, 2024 | 4.084 |
| March 26, 2024 | 4.072 |
| March 25, 2024 | 4.062 |
| March 22, 2024 | 4.088 |
| March 21, 2024 | 4.091 |
| March 20, 2024 | 4.086 |
| March 19, 2024 | 4.072 |
| Date | Value |
|---|---|
| March 18, 2024 | 4.057 |
| March 15, 2024 | 4.076 |
| March 14, 2024 | 4.053 |
| March 13, 2024 | 4.080 |
| March 12, 2024 | 4.102 |
| March 11, 2024 | 4.076 |
| March 08, 2024 | 4.094 |
| March 07, 2024 | 4.113 |
| March 06, 2024 | 4.108 |
| March 05, 2024 | 4.079 |
| March 04, 2024 | 4.104 |
| March 01, 2024 | 4.153 |
| February 29, 2024 | 4.083 |
| February 28, 2024 | 4.174 |
| February 27, 2024 | 4.198 |
| February 26, 2024 | 4.181 |
| February 23, 2024 | 4.146 |
| February 22, 2024 | 4.078 |
| February 21, 2024 | 4.027 |
| February 20, 2024 | 4.002 |
| February 16, 2024 | 4.006 |
| February 15, 2024 | 4.035 |
| February 14, 2024 | 4.006 |
| February 13, 2024 | 3.974 |
| February 12, 2024 | 4.002 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.863
Minimum
Oct 02 2019
7.705
Maximum
Jul 20 2020
4.137
Average
3.810
Median
Dec 14 2022
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.888 |
| Eli Lilly and Co | 64.60 |
| AbbVie Inc | 28.63 |
| Amgen Inc | 23.49 |
| Pfizer Inc | 1.667 |
Price to Book Value Related Metrics
| PE Ratio | 26.10 |
| PS Ratio | 7.864 |
| Price to Free Cash Flow | 28.12 |
| Price | 906.80 |
| Earnings Yield | 3.83% |
| Market Cap | 99.53B |
| Operating PE Ratio | 24.37 |
| Normalized PE Ratio | 23.65 |